Search
NN-8828
go.drugbank.com/drugs/DB18361InvestigationalNN-8828 is an anti-interleukin 21 monoclonal antibody.
Field mushroom
go.drugbank.com/drugs/DB15605ApprovedField mushroom allergenic extract is used in allergenic testing.
Moricizine
go.drugbank.com/drugs/DB00680ApprovedWithdrawnAn antiarrhythmia agent used primarily for ventricular rhythm disturbances.
Synonyms: ethyl 10-(β-N-morpholinylpropionyl)phenothiazine-2-carbamateXL784
go.drugbank.com/drugs/DB04991InvestigationalXL784 is a potent inhibitor of the ADAM-10 metalloprotease enzyme, a target of significant interest because of its important role in blood vessel formation and cell proliferation.
CP-96345
go.drugbank.com/drugs/DB16744ExperimentalCategories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalRuvB-like 2
go.drugbank.com/bio_entities/BE0009019TargetHumansPossesses single-stranded DNA-stimulated ATPase and ATP-dependent DNA helicase (5' to 3') activity; hexamerization is thought to be critical for ATP hydrolysis and adjacent subunits in the ring-like structure contribute to the ATPase act...
Synonyms: 48 kDa TATA box-binding protein-interacting proteinE3 ubiquitin-protein ligase UHRF1
go.drugbank.com/bio_entities/BE0018559TargetHumansE3 ubiquitin-protein ligase that acts as a key epigenetic regulator by bridging DNA methylation and chromatin modification (PubMed:10646863, PubMed:15009091, PubMed:19056828, PubMed:23022729, PubMed:24013172, PubMed:27595565, PubMed:3010...
Synonyms: Inverted CCAAT box-binding protein of 90 kDaFentiazac
go.drugbank.com/drugs/DB13217ExperimentalCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSPozanicline
go.drugbank.com/drugs/DB05458InvestigationalIn radioligand binding studies, ABT-089 has shown selectivity toward the alpha4beta2 nAChR subtype as compared to the alpha7 and alpha1beta1deltagamma nAChR subtypes.
RESP301
go.drugbank.com/drugs/DB16497InvestigationalIt was studied in community patients at risk of viral infections, including SARS-CoV-2, in a terminated trial (NCT04858451) and adults with rifampicin-susceptible pulmonary tuberculosis in a recruiting … RESP301 was also studied in a terminated trial (NCT05101915) for patients with mycobacterium abscesses and cystic fibrosis and in a completed trial with results (NCT04460183) for efficacy and safety in